Advances in myelodysplastic syndrome
30 Mar 2011
Advances in myelodysplastic syndrome
Cytogenetic scoring system for MDS
Clinical trial design for research into cancer in the elderly
Ethical considerations surrounding cancer in the elderly and the pros and cons of web-based resources
Classification of thymic tumours
Role of predictive markers in personalised cancer treatment
The role of comorbidity indices in the prognosis of elderly MDS patients
The importance of myelodysplastic syndrome diagnosis
Active monitoring of prostate cancer
Oncotype DX testing to determine adjuvant therapy for breast cancer patients
Issues with reliability in HER2 testing and avastin for metastatic breast cancer
Next generation gene sequencing